| For: | Choochuay K, Kunhapan P, Puangpetch A, Tongsima S, Srisawasdi P, Sobhonslidsuk A, Sungkanuparph S, Biswas M, Sukasem C. Associations of PNPLA3 and LEP genetic polymorphisms with metabolic-associated fatty liver disease in Thai people living with human immunodeficiency virus. World J Hepatol 2024; 16(3): 366-378 [PMID: 38577531 DOI: 10.4254/wjh.v16.i3.366] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v16/i3/366.htm |
| Number | Citing Articles |
| 1 |
Yuanxing Lu, Qi Peng, Beizhong Liu, Bo Xie. SIRT5 affects lipid accumulation in cells of a metabolic-associated fatty liver disease model by regulating the succinylation status of HSPD1. BMC Immunology 2025; 26(1) doi: 10.1186/s12865-025-00776-7
|
| 2 |
Rahnuma Ahmad, Mainul Haque. Metformin: Beyond Type 2 Diabetes Mellitus. Cureus 2024; doi: 10.7759/cureus.71730
|
| 3 |
Ralf Weiskirchen, Amedeo Lonardo. PNPLA3 as a driver of steatotic liver disease: navigating from pathobiology to the clinics via epidemiology. Journal of Translational Genetics and Genomics 2024; 8(4): 355 doi: 10.20517/jtgg.2024.70
|
